J&J MedTech wins IDE for Ottava to greenlight trials for surgical robot
J&J MedTech is aiming to disrupt a robotic surgical market dominated by Intuitive’s Da Vinci systems.
J&J MedTech is aiming to disrupt a robotic surgical market dominated by Intuitive’s Da Vinci systems.